FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891907584> ?p ?o ?g. }

• W2891907584 endingPage "2814" @default.
• W2891907584 startingPage "2805" @default.
• W2891907584 abstract "The Epstein-Barr virus (EBV)-associated cancer nasopharyngeal carcinoma (NPC) is rare in Europe and North America but is a real public health problem in some regions of the world, such as southern Asia, North Africa, and for Inuit populations. Due to the anatomy and location of the nasopharynx, surgery is rarely used to treat primary NPC cancers. Treatment by radiotherapy, combined or not with chemotherapy, are efficient for primary tumors but often do not protect against fatal relapses or metastases.Search for new therapeutic molecules through high content screening lead to the identification of Ivermectin (IVM) as a promising drug. IVM is a US Food and Drug Administration-approved macrocyclic lactone widely used as anthelmintic and insecticidal agent that has also shown protective effects against cancers.We show here that IVM has cytotoxic activity in vitro against NPC cells, in which it reduces MAPKs pathway activation through the inhibition PAK-1 activity. Moreover, all macrocyclic lactones tested and a PAK1 inhibitor are cytotoxic in vitro for EBV-positive and EBV-negative NPC tumor cells. We have also shown that IVM intraperitoneal repeated injections, at US Food and Drug Administration-approved doses, have no significant toxicity and decrease NPC subcutaneous tumors development in nude mice.Macrocyclic lactones appear as promising molecules against NPC targeting PAK-1 with no detectable adverse effect." @default.
• W2891907584 created "2018-09-27" @default.
• W2891907584 creator A5030498342 @default.
• W2891907584 creator A5032064496 @default.
• W2891907584 creator A5034436415 @default.
• W2891907584 creator A5089146837 @default.
• W2891907584 date "2018-09-01" @default.
• W2891907584 modified "2023-10-18" @default.
• W2891907584 title "Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth" @default.
• W2891907584 cites W1983514454 @default.
• W2891907584 cites W1991261802 @default.
• W2891907584 cites W2009174042 @default.
• W2891907584 cites W2009906545 @default.
• W2891907584 cites W2016313593 @default.
• W2891907584 cites W2027719557 @default.
• W2891907584 cites W2037163044 @default.
• W2891907584 cites W2071424589 @default.
• W2891907584 cites W2073301179 @default.
• W2891907584 cites W2078983800 @default.
• W2891907584 cites W2096238525 @default.
• W2891907584 cites W2104865237 @default.
• W2891907584 cites W2111509141 @default.
• W2891907584 cites W2123302006 @default.
• W2891907584 cites W2131465172 @default.
• W2891907584 cites W2141116320 @default.
• W2891907584 cites W2591509255 @default.
• W2891907584 cites W2593557252 @default.
• W2891907584 cites W2604017328 @default.
• W2891907584 cites W2779452291 @default.
• W2891907584 cites W2779786953 @default.
• W2891907584 cites W2789220621 @default.
• W2891907584 cites W4210983491 @default.
• W2891907584 doi "https://doi.org/10.2147/dddt.s172538" @default.
• W2891907584 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6135081" @default.
• W2891907584 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30233143" @default.
• W2891907584 hasPublicationYear "2018" @default.
• W2891907584 type Work @default.
• W2891907584 sameAs 2891907584 @default.
• W2891907584 citedByCount "14" @default.
• W2891907584 countsByYear W28919075842019 @default.
• W2891907584 countsByYear W28919075842020 @default.
• W2891907584 countsByYear W28919075842021 @default.
• W2891907584 countsByYear W28919075842022 @default.
• W2891907584 countsByYear W28919075842023 @default.
• W2891907584 crossrefType "journal-article" @default.
• W2891907584 hasAuthorship W2891907584A5030498342 @default.
• W2891907584 hasAuthorship W2891907584A5032064496 @default.
• W2891907584 hasAuthorship W2891907584A5034436415 @default.
• W2891907584 hasAuthorship W2891907584A5089146837 @default.
• W2891907584 hasBestOaLocation W28919075841 @default.
• W2891907584 hasConcept C121608353 @default.
• W2891907584 hasConcept C126322002 @default.
• W2891907584 hasConcept C150903083 @default.
• W2891907584 hasConcept C154317977 @default.
• W2891907584 hasConcept C202751555 @default.
• W2891907584 hasConcept C203014093 @default.
• W2891907584 hasConcept C207001950 @default.
• W2891907584 hasConcept C2778997737 @default.
• W2891907584 hasConcept C502942594 @default.
• W2891907584 hasConcept C509974204 @default.
• W2891907584 hasConcept C55493867 @default.
• W2891907584 hasConcept C71924100 @default.
• W2891907584 hasConcept C86803240 @default.
• W2891907584 hasConcept C98274493 @default.
• W2891907584 hasConceptScore W2891907584C121608353 @default.
• W2891907584 hasConceptScore W2891907584C126322002 @default.
• W2891907584 hasConceptScore W2891907584C150903083 @default.
• W2891907584 hasConceptScore W2891907584C154317977 @default.
• W2891907584 hasConceptScore W2891907584C202751555 @default.
• W2891907584 hasConceptScore W2891907584C203014093 @default.
• W2891907584 hasConceptScore W2891907584C207001950 @default.
• W2891907584 hasConceptScore W2891907584C2778997737 @default.
• W2891907584 hasConceptScore W2891907584C502942594 @default.
• W2891907584 hasConceptScore W2891907584C509974204 @default.
• W2891907584 hasConceptScore W2891907584C55493867 @default.
• W2891907584 hasConceptScore W2891907584C71924100 @default.
• W2891907584 hasConceptScore W2891907584C86803240 @default.
• W2891907584 hasConceptScore W2891907584C98274493 @default.
• W2891907584 hasLocation W28919075841 @default.
• W2891907584 hasLocation W28919075842 @default.
• W2891907584 hasLocation W28919075843 @default.
• W2891907584 hasLocation W28919075844 @default.
• W2891907584 hasLocation W28919075845 @default.
• W2891907584 hasLocation W28919075846 @default.
• W2891907584 hasLocation W28919075847 @default.
• W2891907584 hasOpenAccess W2891907584 @default.
• W2891907584 hasPrimaryLocation W28919075841 @default.
• W2891907584 hasRelatedWork W1566729005 @default.
• W2891907584 hasRelatedWork W1700716001 @default.
• W2891907584 hasRelatedWork W2052574963 @default.
• W2891907584 hasRelatedWork W2138350991 @default.
• W2891907584 hasRelatedWork W2356304706 @default.
• W2891907584 hasRelatedWork W2384038617 @default.
• W2891907584 hasRelatedWork W2409285845 @default.
• W2891907584 hasRelatedWork W2434195791 @default.
• W2891907584 hasRelatedWork W3015376786 @default.
• W2891907584 hasRelatedWork W4292382459 @default.
• W2891907584 hasVolume "Volume 12" @default.

• next